X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/additional-drugmakers-flag-risks-of-working-with-wuxi-amid-heightened-us-scrutiny/
https://www.globenewswire.com/news-release/2024/03/21/2850085/0/en/Cabaletta-Bio-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/03/20/2849225/0/en/Cabaletta-Bio-Announces-FDA-Granted-Orphan-Drug-Designation-to-CABA-201-for-Treatment-of-Systemic-Sclerosis.html
https://www.globenewswire.com//news-release/2024/02/27/2835938/0/en/Cabaletta-Bio-to-Participate-in-Upcoming-Investor-Conferences-in-March.html
https://www.globenewswire.com//news-release/2024/02/01/2822479/0/en/Cabaletta-Bio-Announces-FDA-Granted-Orphan-Drug-Designation-to-CABA-201-for-Treatment-of-Myositis.html
https://www.globenewswire.com/news-release/2024/01/31/2821065/0/en/Cabaletta-Bio-to-Participate-in-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/01/08/2805284/0/en/Cabaletta-Bio-Receives-Additional-FDA-Fast-Track-Designations-for-CABA-201-in-Dermatomyositis-and-Systemic-Sclerosis.html
https://www.globenewswire.com//news-release/2024/01/02/2802636/0/en/Cabaletta-Bio-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/28/2787379/0/en/Cabaletta-Bio-to-Participate-in-the-6th-Annual-Evercore-ISI-HealthCONx-Conference.html
https://www.globenewswire.com//news-release/2023/11/09/2777162/0/en/Cabaletta-Bio-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
Market Place
Share 
